Non-invasive Brain Stimulation System Market

Non-invasive Brain Stimulation System Market (Product Type: Transcranial Magnetic Stimulation [TMS] System and Transcranial Current Stimulation [TCS] System) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Non-invasive Brain Stimulation System Market Outlook 2031

  • The global non-invasive brain stimulation system market was valued at US$ 580.3 Mn in 2021
  • The global market is projected to grow at a CAGR of 6.3% from 2022 to 2031
  • The global non-invasive brain stimulation system market is anticipated to reach more than US$ 1.04 Bn by the end of 2031

Analysts’ Viewpoint on Non-invasive Brain Stimulation System Market Scenario

Non-invasive technology is making revolutionary changes in the healthcare industry. It provides advantages such as less pain, reduced discomfort, and fast treatment. Non-invasive brain stimulation is a technology used to alter brain activity without an incision. Currently, therapeutic drugs are the primary treatment options for diseases such as depression, epilepsy, Parkinson’s disease, and chronic pain. Non-invasive brain stimulation is used when drug treatment fails or is ineffective. The number of patients with depression, epilepsy, and other brain related disorders has increased over the last few years. Key medical devices manufacturers are focusing on design and development of new devices for non-invasive brain stimulation.

Non Invasive Brain Stimulation System Market

Non-invasive Brain Stimulation System Market Introduction

Non-invasive brain stimulation is a set of technologies and techniques used to stimulate or alter brain activity from the surface of the head without the introduction of instruments inside the body or breaking the skin. Transcranial magnetic stimulation (TMS) and Transcranial Current Stimulation (TCS) are the two primary methods of non-invasive brain stimulation. The process of transcranial magnetic stimulation involves the production of magnetic pulses easily transferable to the skull and other matter present in the brain. An electrical potential is created in the brain that depolarizes neurons present there and triggers various actions. Transcranial magnetic stimulation (TMS) system is most commonly used in depression, when other depression treatments prove ineffective. Transcranial current stimulation includes alternating current (AC) or direct current (DC), with one electrode put on the head and the other on the target area of the brain.

Non-invasive brain stimulation system is most commonly used in diseases such as depression, epilepsy, Parkinson’s disease, and chronic pain. Incidence of these diseases has increased in countries such as India, China, and Brazil. The global non-invasive brain stimulation system market demand is driven by the increase in preference for non-invasive technology and rise in number of patients suffering from depression and Parkinson’s disease.

Request a sample to get extensive insights into the Non-invasive Brain Stimulation System Market

Rise in Incidence of Depression and Parkinson’s Disease to Drive Global Market

Preference for non-invasive technology, especially brain stimulation, has increased over the last few years. Non-invasive procedures are performed without anesthesia. Non-invasive technology causes minimal complications, reduces the risk of infections, causes less pain & discomfort, and offers rapid recovery. This leads to shorter hospital stay than traditional therapies and treatments.

The burden of brain-related disorders is expected to rise significantly across the globe in the next few years. According to the World Health Organization, depression is a leading cause of disability across the world, and is a major contributor to the overall global burden of the disease. Around 280 million people in the world suffer from depression. China accounts for the largest number of people with Parkinson’s disease in the world. Currently, around 2.5 million people in the country are afflicted with the disease. This number is expected to double by the end of 2030, accounting for 50% of the global population. Currently, 1.7% of the population above the age of 65 is affected by the Parkinson’s disease in China.

Increase in Research & Development Activities to Propel Transcranial Magnetic Stimulation System Segment

In terms of product type, the transcranial magnetic stimulation (TMS) system segment accounted for significant market share in 2021. Transcranial magnetic stimulation is a noninvasive treatment used for depression. It is employed when other depression treatments have been ineffective. Transcranial magnetic stimulation (TMS) includes deep transcranial magnetic stimulation and repetitive transcranial magnetic stimulation. As per non-invasive brain stimulation system market analysis, increase in research & development activities in transcranial magnetic stimulation (TMS) products is likely to drive the segment during the forecast period. Surge in usage of TMS in the treatment of disorders such as depression, epilepsy, and Parkinson’s diseases is likely to propel the segment during forecast period. Key market players are focusing on launching innovative products. This is projected to augment the segment. For instance, in March 2021, MagVenture introduced MagVenture Flow Arm used in non-invasive brain stimulation.

Launch of New Treatment Devices Fueling Depression Segment

Based on application, the depression segment held major share of the global non-invasive brain stimulation system market in 2021. Increase in incidence of depressive disorders is anticipated to drive the segment. According to the World Health Organization, an estimated 5% of adults suffer from depression across the globe. The global non-invasive brain stimulation system market trends indicate that major players are focusing on the launch of new devices for the treatment of depression. This is likely to augment the depression segment. For instance, in March 2020, Neuronetics launched NeuroStar, which is the first transcranial magnetic stimulation (TMS) device to receive Breakthrough Device Designation for bipolar depression.

Favorable Medical Reimbursement for Non-invasive Brain Stimulation Systems Bolstering Hospitals Segment

In terms of end-user, the hospitals segment is expected to account for major share of the global non-invasive brain stimulation system market during the forecast period. Well-established health care infrastructure, favorable medical reimbursement facilities for non-invasive brain stimulation systems in developed countries, and comparative high cost of devices contributed to the segment's large market share in 2021. Furthermore, rise in number of hospitals in developing countries and growth in number of neurological disorders are likely to drive the segment during the forecast period

Regional Outlook of Global Non-invasive Brain Stimulation System Market

North America held the largest share of around 40% of the global non-invasive brain stimulation system market in 2021. The region is expected to be a highly lucrative market during the forecast period. North America's dominance of the global market can be ascribed to the increase in incidence of major neurological diseases in the region. The U.S. dominated the market in North America owing to factors such as presence of key market players and increase in the research & development activities in the non-invasive brain stimulation field.

Asia Pacific is projected to be the fastest growing region of the global non-invasive brain stimulation system market during the forecast period. The market in the region is anticipated to grow at a rapid pace from 2022 to 2031 due to high incidence rate of depression, epilepsy, and Parkinson’s disease.

Analysis of Key Players in Global Non-invasive Brain Stimulation System Market

The global non-invasive brain stimulation system market is fragmented, with the presence of large number of leading players. Most of the companies are investing significantly in research & development activities, primarily to introduce innovative products. Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by key players operating in the global non-invasive brain stimulation system market. Brainbox Ltd., BrainsWay, eNeura Inc., Flow Neuroscience, Magnus Medical, Inc., Magstim, MagVenture, NeoSync, Inc. (Wave Neuroscience, Inc.), NeuraLace, Neurocare Group AG, NeuroMetrix, Neuronetics, and Soterix Medical, Inc. are the prominent players operating in the market.

Request a custom report on Non-invasive Brain Stimulation System Market

Key Developments in Global Non-invasive Brain Stimulation System Market

  • In September 2022, Magnus Medical, Inc. received FDA clearance for the SAINT Neuromodulation system for non-invasive, individualized, and precise treatment of severe depression
  • In August 2022, BrainsWay received the U.S. FDA approval for H7 coil to deliver deep transcranial magnetic stimulation for the treatment of adults with major depressive disorder and anxious depression
  • In February 2020, Wave Neuroscience, Inc. acquired NeoSync, Inc. to expand its existing product portfolio and strengthen its position in the EEG and EEG/EKG guided TMS segment

Each of these players has been profiled in the non-invasive brain stimulation system market report based on parameters such as company overview, business strategies, product portfolio, business segments, and recent developments.

Global Non-invasive Brain Stimulation System Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 580.3 Mn

Market Forecast Value in 2031

More than US$ 1.04 Bn

Growth Rate

(CAGR)

6.3%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Mn/Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product Type
    • Transcranial Magnetic Stimulation (TMS) System
    • Transcranial Current Stimulation (TCS) System
  • Application
    • Depression
    • Epilepsy
    • Parkinson's Disease
    • Chronic Pain
    • Others
  • End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries

Companies Profiled

  • Brainbox Ltd.
  • BrainsWay
  • eNeura Inc.
  • Flow Neuroscience
  • Magnus Medical, Inc.
  • Magstim
  • MagVenture
  • NeoSync, Inc. (Wave Neuroscience, Inc.)
  • NeuraLace
  • Neurocare Group AG
  • NeuroMetrix
  • Neuronetics
  • Soterix Medical, Inc.

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global non-invasive brain stimulation market in 2021?

The global non-invasive brain stimulation market was valued at US$ 580.3 Mn in 2021

How big will be the global non-invasive brain stimulation market in 2031?

The global non-invasive brain stimulation market is projected to reach more than US$ 1.04 Bn by 2031

What will be the CAGR of the global non-invasive brain stimulation market during the forecast period (2022–2031)?

The global non-invasive brain stimulation market is anticipated to grow at a CAGR of 6.3% from 2022 to 2031

Which are the prominent trends that affect market growth?

Increase in preference for non-invasive technology, and rise in incidence of depression and Parkinson’s disease

Which region will account for major share of the global market during the forecast period?

North America is likely to account for major share of the global non-invasive brain stimulation market during the forecast period

Who are the prominent players in the global non-invasive brain stimulation market?

Brainbox Ltd., BrainsWay, eNeura Inc., Flow Neuroscience, Magnus Medical, Inc., Magstim, MagVenture, NeoSync, Inc. (Wave Neuroscience, Inc.), NeuraLace, Neurocare Group AG, NeuroMetrix, Neuronetics, and Soterix Medical, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

        2.1. Assumptions and Acronyms Used

        2.2. Research Methodology

    3. Executive Summary

    4. Market Overview

        4.1. Introduction

        4.2. Market Dynamics

            4.2.1. Drivers

            4.2.2. Restraints

            4.2.3. Opportunity

        4.3. Global Non-invasive Brain Stimulation System Market Forecast

        4.4. Global Non-invasive Brain Stimulation System Market Outlook

    5. Market Outlook

        5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)

        5.2. Key product/Brand Analysis

        5.3. Diseases Epidemiology

        5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    6. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by Product Type

        6.1. Introduction

        6.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type

        6.3. Global Non-invasive Brain Stimulation System Market Forecast, by Product Type

            6.3.1. Transcranial Magnetic Stimulation (TMS) System

            6.3.2. Transcranial Current Stimulation (TCS) System

        6.4. Global Non-invasive Brain Stimulation System Market Analysis, by Product Type

    7. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by Application

        7.1. Introduction

        7.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application

        7.3. Global Non-invasive Brain Stimulation System Market Forecast, by Application

            7.3.1. Depression

            7.3.2. Epilepsy

            7.3.3. Parkinson’s Disease

            7.3.4. Chronic Pain

            7.3.5. Others

        7.4. Global Non-invasive Brain Stimulation System Market Analysis, by Application

    8. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by End-user

        8.1. Introduction

        8.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user

        8.3. Global Non-invasive Brain Stimulation System Market Forecast, by End-user

            8.3.1. Hospitals

            8.3.2. Ambulatory Surgical Centers

            8.3.3. Specialty Clinics

            8.3.4. Others

        8.4. Global Non-invasive Brain Stimulation System Market Analysis, by End-user

    9. Global Non-invasive Brain Stimulation System Market Analysis, by Region

        9.1. Global Non-invasive Brain Stimulation System Market Analysis, by Region

        9.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Region

        9.3. Global Non-invasive Brain Stimulation System Market Forecast, by Region

            9.3.1. North America

            9.3.2. Europe

            9.3.3. Asia Pacific

            9.3.4. Latin America

            9.3.5. Middle East & Africa

    10. North America Non-invasive Brain Stimulation System Market Analysis

        10.1. North America Non-invasive Brain Stimulation System Market Overview

        10.2. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country

        10.3. North America Non-invasive Brain Stimulation System Market Forecast, by Country

            10.3.1. U.S.

            10.3.2. Canada

        10.4. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type

        10.5. North America Non-invasive Brain Stimulation System Market Forecast, by Product Type

            10.5.1. Transcranial Magnetic Stimulation (TMS) System

            10.5.2. Transcranial Current Stimulation (TCS) System

        10.6. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application

        10.7. North America Non-invasive Brain Stimulation System Market Forecast, by Application

            10.7.1. Depression

            10.7.2. Epilepsy

            10.7.3. Parkinson’s Disease

            10.7.4. Chronic Pain

            10.7.5. Others

        10.8. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user

        10.9. North America Non-invasive Brain Stimulation System Market Forecast, by End-user

            10.9.1. Hospitals

            10.9.2. Ambulatory Surgical Centers

            10.9.3. Specialty Clinics

            10.9.4. Others

    11. Europe Non-invasive Brain Stimulation System Market Analysis

        11.1. Europe Non-invasive Brain Stimulation System Market Overview

        11.2. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region

        11.3. Europe Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region

            11.3.1. Germany

            11.3.2. U.K.

            11.3.3. France

            11.3.4. Italy

            11.3.5. Spain

            11.3.6. Rest of Europe

        11.4. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type

        11.5. Europe Non-invasive Brain Stimulation System Market Forecast, by Product Type

            11.5.1. Transcranial Magnetic Stimulation (TMS) System

            11.5.2. Transcranial Current Stimulation (TCS) System

        11.6. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application

        11.7. Europe Non-invasive Brain Stimulation System Market Forecast, by Application

            11.7.1. Depression

            11.7.2. Epilepsy

            11.7.3. Parkinson’s Disease

            11.7.4. Chronic Pain

            11.7.5. Others

        11.8. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user

        11.9. Europe Non-invasive Brain Stimulation System Market Forecast, by End-user

            11.9.1. Hospitals

            11.9.2. Ambulatory Surgical Centers

            11.9.3. Specialty Clinics

            11.9.4. Others

    12. Asia Pacific Non-invasive Brain Stimulation System Market Analysis

        12.1. Asia Pacific Non-invasive Brain Stimulation System Market Overview

        12.2. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region

        12.3. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region

            12.3.1. China

            12.3.2. India

            12.3.3. Japan

            12.3.4. Australia & New Zealand

            12.3.5. Rest of Asia Pacific

        12.4. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type

        12.5. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Product Type

            12.5.1. Transcranial Magnetic Stimulation (TMS) System

            12.5.2. Transcranial Current Stimulation (TCS) System

        12.6. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application

        12.7. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Application

            12.7.1. Depression

            12.7.2. Epilepsy

            12.7.3. Parkinson’s Disease

            12.7.4. Chronic Pain

            12.7.5. Others

        12.8. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user

        12.9. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by End-user

            12.9.1. Hospitals

            12.9.2. Ambulatory Surgical Centers

            12.9.3. Specialty Clinics

            12.9.4. Others

    13. Latin America Non-invasive Brain Stimulation System Market Analysis

        13.1. Latin America Non-invasive Brain Stimulation System Market Overview

        13.2. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region

        13.3. Latin America Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region

            13.3.1. Brazil

            13.3.2. Mexico

            13.3.3. Rest of Latin America

        13.4. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type

        13.5. Latin America Non-invasive Brain Stimulation System Market Forecast, by Product Type

            13.5.1. Transcranial Magnetic Stimulation (TMS) System

            13.5.2. Transcranial Current Stimulation (TCS) System

        13.6. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application

        13.7. Latin America Non-invasive Brain Stimulation System Market Forecast, by Application

            13.7.1. Depression

            13.7.2. Epilepsy

            13.7.3. Parkinson’s Disease

            13.7.4. Chronic Pain

            13.7.5. Others

        13.8. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user

        13.9. Latin America Non-invasive Brain Stimulation System Market Forecast, by End-user

            13.9.1. Hospitals

            13.9.2. Ambulatory Surgical Centers

            13.9.3. Specialty Clinics

            13.9.4. Others

    14. Middle East & Africa Non-invasive Brain Stimulation System Market Analysis

        14.1. Middle East & Africa Non-invasive Brain Stimulation System Market Overview

        14.2. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country

        14.3. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region

            14.3.1. GCC Countries

            14.3.2. South Africa

            14.3.3. Rest of Middle East & Africa

        14.4. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type

        14.5. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Product Type

            14.5.1. Transcranial Magnetic Stimulation (TMS) System

            14.5.2. Transcranial Current Stimulation (TCS) System

        14.6. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application

        14.7. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Application

            14.7.1. Depression

            14.7.2. Epilepsy

            14.7.3. Parkinson’s Disease

            14.7.4. Chronic Pain

            14.7.5. Others

        14.8. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user

        14.9. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by End-user

            14.9.1. Hospitals

            14.9.2. Ambulatory Surgical Centers

            14.9.3. Specialty Clinics

            14.9.4. Others

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Company Profiles

            15.2.1. Brainbox Ltd.

                15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.1.2. Product Portfolio

                15.2.1.3. Financial Overview

                15.2.1.4. Strategic Overview

                15.2.1.5. SWOT Analysis

            15.2.2. BrainsWay

                15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.2.2. Product Portfolio

                15.2.2.3. Strategic Overview

                15.2.2.4. SWOT Analysis

            15.2.3. eNeura, Inc.

                15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.3.2. Product Portfolio

                15.2.3.3. Strategic Overview

                15.2.3.4. SWOT Analysis

            15.2.4. Flow Neuroscience

                15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.4.2. Product Portfolio

                15.2.4.3. Strategic Overview

                15.2.4.4. SWOT Analysis

            15.2.5. Magnus Medical, Inc.

                15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.5.2. Product Portfolio

                15.2.5.3. Strategic Overview

                15.2.5.4. SWOT Analysis

            15.2.6. Magstim

                15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.6.2. Product Portfolio

                15.2.6.3. Strategic Overview

                15.2.6.4. SWOT Analysis

            15.2.7. MagVenture

                15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.7.2. Product Portfolio

                15.2.7.3. Strategic Overview

                15.2.7.4. SWOT Analysis

            15.2.8. NeoSync, Inc. (Wave Neuroscience, Inc.)

                15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.8.2. Product Portfolio

                15.2.8.3. Strategic Overview

                15.2.8.4. SWOT Analysis

            15.2.9. NeuraLace

                15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.9.2. Product Portfolio

                15.2.9.3. Strategic Overview

                15.2.9.4. SWOT Analysis

            15.2.10. neurocare group AG

                15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.10.2. Product Portfolio

                15.2.10.3. Strategic Overview

                15.2.10.4. SWOT Analysis

            15.2.11. NeuroMetrix

                15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.11.2. Product Portfolio

                15.2.11.3. Strategic Overview

                15.2.11.4. SWOT Analysis

            15.2.12. Neuronetics

                15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.12.2. Product Portfolio

                15.2.12.3. Strategic Overview

                15.2.12.4. SWOT Analysis

            15.2.13. Soterix Medical, Inc.

                15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.13.2. Product Portfolio

                15.2.13.3. Strategic Overview

    List of Tables

    Table 01: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 02: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 03: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 07: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 08: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 11: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 12: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 15: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 16: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 19: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 20: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 23: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 24: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 25: Brainbox Ltd. Business Overview

    Table 26: BrainsWay Business Overview

    Table 27: eNeura Inc. Overview

    Table 28: Flow Neuroscience Business Overview

    Table 29: Magnus Medical, Inc. Business Overview

    Table 30: Magstim Business Overview

    Table 31: MagVenture Business Overview

    Table 32: NeoSync, Inc. (Wave Neuroscience, Inc.) Business Overview

    Table 33: NeuraLace Business Overview

    Table 34: neurocare group AG Business Overview

    Table 35: NeuroMetrix Business Overview

    Table 36: Neuronetics Business Overview

    Table 37: Soterix Medical, Inc.Business Overview

    List of Figures

    Figure 01: Market Share, by Product Type

    Figure 02: Market Share, by Application

    Figure 03: Market Share, by Region

    Figure 04: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, 2017–2031

    Figure 05: Global Non-invasive Brain Stimulation System Market Value Share, by Product Type, 2021

    Figure 06: Global Non-invasive Brain Stimulation System Market Value Share, by End-user, 2021

    Figure 07: Global Non-invasive Brain Stimulation System Market Value Share, by Application, 2021

    Figure 08: Global Non-invasive Brain Stimulation System Market Value Share, by Region, 2021

    Figure 09: Global Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031

    Figure 10: Global Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 11: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Transcranial Magnetic Stimulation (TMS) System, 2017–2031

    Figure 12: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Transcranial Current Stimulation (TCS) System, 2017–2031

    Figure 13: Global Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031

    Figure 14: Global Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022–2031

    Figure 15: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Depression, 2017–2031

    Figure 16: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Epilepsy, 2017–2031

    Figure 17: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Parkinson’s Disease, 2017–2031

    Figure 18: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Chronic Pain, 2017–2031

    Figure 19: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 20: Global Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 21: Global Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 22: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Hospitals, 2017–2031

    Figure 23: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017–2031

    Figure 24: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Specialty Clinic, 2017–2031

    Figure 25: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 26: Global Non-invasive Brain Stimulation System Market Value Share Analysis, by Region, 2021 and 2031

    Figure 27: Global Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Region, 2022-2031

    Figure 28: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 29: North America Non-invasive Brain Stimulation System Market Value Share (%), by Country, 2021 and 2031

    Figure 30: North America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country, 2022–2031

    Figure 31: North America Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031

    Figure 32: North America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 33: North America Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031

    Figure 34: North America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022–2031

    Figure 35: North America Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 36: North America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 37: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 38: Europe Non-invasive Brain Stimulation System Market Value Share (%), by Country/Sub-region, 2021 and 2031

    Figure 39: Europe Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 40: Europe Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031

    Figure 41: Europe Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 42: Europe Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031

    Figure 43: Europe Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022–2031

    Figure 44: Europe Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 45: Europe Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 46: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 47: Asia Pacific Non-invasive Brain Stimulation System Market Value Share (%), by Country/Sub-region, 2021 and 2031

    Figure 48: Asia Pacific Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 49: Asia Pacific Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031

    Figure 50: Asia Pacific Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 51: Asia Pacific Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031

    Figure 52: Asia Pacific Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022–2031

    Figure 53: Asia Pacific Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 54: Asia Pacific Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 55: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 56: Latin America Non-invasive Brain Stimulation System Market Value Share (%), by Country/Sub-region, 2021 and 2031 

    Figure 57: Latin America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 58: Latin America Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031 

    Figure 59: Latin America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 60: Latin America Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031

    Figure 61: Latin America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022–2031

    Figure 62: Latin America Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 63: Latin America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 64: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 65: Middle East & Africa Non-invasive Brain Stimulation System Market Value Share (%), by Country/Sub-region, 2021 and 2031

    Figure 66: Middle East & Africa Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 67: Middle East & Africa Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031

    Figure 68: Middle East & Africa Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 69: Middle East & Africa Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031

    Figure 70: Middle East & Africa Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022–2031

    Figure 71: Middle East & Africa Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 72: Middle East & Africa Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022–2031

Copyright © Transparency Market Research, Inc. All Rights reserved